IFNA1 and cancer: In contrast, our results point to a rapid and sustained normalization of IFN signaling with DAA therapy; whether this consistent finding across multiple T cell populations informs other areas such as response to vaccination [11] [3], susceptibility and response to other infections [51], and risk of cancer development post-SVR [52] warrants further study.